Evidence map›Paper›PMID 37681202›Full record

ReviewFrontiers in pediatrics2023

Risk and diagnostic factors and therapy outcome of neonatal early onset sepsis in ICU patients of Saudi Arabia: a systematic review and meta analysis.

Mohammed K Alshammari, Ahlam H Alsanad, Rawan J Alnusayri, Abdulmajeed S Alanazi, Fatmah Q Shamakhi, Khaled M Alshahrani, Abdullah M Alshahrani, Ghaliah Yahya, Abdulaziz A Alshahrani, Turki S Alshahrani and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Diagnostics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Mohammed K AlshammariDepartment of Clinical Pharmacy, King Fahad Medical City Hospital, Riyadh, Saudi Arabia.
Ahlam H AlsanadDepartment of Neonatal Intensive Care Unit, Maternity and Children Hospital, Dammam, Saudi Arabia.
Rawan J AlnusayriDepartment of Pharmacy, Maternity and Children Hospital, Ministry of Health, Jouf, Saudi Arabia.
Abdulmajeed S AlanaziDepartment of Medicine, Ministry of Health, Abha, Saudi Arabia.
Fatmah Q ShamakhiDepartment of Medicine, Ministry of Health, Abha, Saudi Arabia.
Khaled M AlshahraniDepartment of Medicine, Ministry of Health, Abha, Saudi Arabia.
Abdullah M AlshahraniDepartment of Medicine, Ministry of Health, Khamis Mushait, Saudi Arabia.
Ghaliah YahyaDepartment of Medicine, Ministry of Health, Abha, Saudi Arabia.
Abdulaziz A AlshahraniDepartment of Medicine, King Khaled University, Abha, Saudi Arabia.
Turki S AlshahraniCollege of Medicine, King Khalid University, Al Fara, Saudi Arabia.
Hamad S SultanCollege of Medicine, King Khalid University, Al Fara, Saudi Arabia.
Fatimah M AlshahraniDepartment of Pharmacy, Dr. Sulaiman Al-Habib Hospital, Khobar, Saudi Arabia.
Fouzyia A AlreshidiDepartment of Nursing Office, Hail General Hospital, Hail, Saudi Arabia.
Renad A AlnigaidanDepartment of Pharmacy, Al-Dawaa Medical Services Company Limited, Unaizah, Saudi Arabia.
Abdulaziz A AlmazyadDepartment of Pharmacy, Qassim University Medical City Hospital, Buraidah, Saudi Arabia.
Ministry of Health · SAKing Khalid University · SAKing Fahd Medical City · SAKing Khaled Hospital · SAMaternity and Children's Hospital · SAQassim University · SASaad Specialist Hospital · SAUniversity of Ha'il · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neonatal early onset sepsis (NEOS) is a serious and potentially life-threatening condition affecting newborns within the first few days of life. While the diagnosis of NEOS was based on clinical signs and symptoms in the past, recent years have seen growing interest in identifying specific diagnostic factors and optimizing therapy outcomes. This study aims to investigate the diagnostic and risk factors and therapy outcomes of neonatal EOS in ICU patients in Saudi Arabia, with the goal of improving the management of neonatal EOS in the country. Methods: This method outlines the protocol development, search strategy, study selection, and data collection process for a systematic review on neonatal early onset sepsis in Saudi Arabian ICU patients, following the PRISMA 2020 guidelines. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a well-established guideline that provides a framework for conducting systematic reviews and meta-analyses in a transparent and standardized manner. It aims to improve the quality and reporting of such research by ensuring clear and comprehensive reporting of study methods, results, and interpretations. The search strategy included electronic databases (PubMed, Embase, Google Scholar, Science Direct, and the Cochrane Library) and manual search of relevant studies, and data were extracted using a standardized form. Results: The systematic review included 21 studies on neonatal sepsis in Saudi Arabia, with varying study designs, sample sizes, and prevalence rates of sepsis. Group B streptococcus and E. coli were the most commonly isolated pathogens. Various diagnostic factors and risk factors were reported, including hematological parameters, biomarkers, and blood cultures. The quality of the included studies was assessed using the Newcastle-Ottawa Scale and Joanna Briggs Institute critical checklist. Conclusions: The review identified a number of risk and diagnostic factors and therapy outcomes for neonatal sepsis. However, most of the studies were having small scale cohort groups. Further research with controlled study designs is needed to develop effective prevention and management strategies for neonatal sepsis in Saudi Arabia.

Indexed as

diagnostic factorsICU patientsneonatal early onset sepsisrisk factorsSaudi Arabiatherapy outcome

Identifiers

PMID37681202
PMCPMC10482413
OpenAlexW4386089788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.